🇺🇸 FDA
Patent

US 9453239

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

granted A61KA61K2039/5256A61K2039/53

Quick answer

US patent 9453239 (Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes) held by The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health
Grant date
Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K2039/57, A61P